Immunofluorescent Monoclonal Antibody Detection of Breast Cancer in Bone Marrow: Sensitivity in a Model System

Michael P. Osborne, Shirin Asina, George Y. Wong, Lloyd J. Old, Richard J. Cote

Research output: Contribution to journalArticlepeer-review

60 Scopus citations


We have previously shown that occult micrometastases can be detected in the bone marrow of breast cancer patients using a panel of epithelial specific monoclonal antibodies in an indirect immunofluorescent assay. The sensitivity of this assay has been examined using cells from an established human breast cancer cell line (MCF-7) mixed with normal bone marrow at various dilutions from 400 cancer cells/106 marrow cells (400:106) to 10:106. MCF-7 cells were detected at the lowest concentration studied, namely 10:106. The number of fluorescent labeled MCF-7 cells counted at each concentration was related to the concentration by a simple nonlinear statistical model. At the concentration of 10:106, the model shows that this technique has the sensitivity to detect between two and four MCF-7 cells 95% of the time. Moreover, by extrapolation, the model predicts that even at the very low concentration of 2:106, there is a 95% chance of detecting one cancer cell. Therefore, this assay may be a very sensitive method for detecting cancer cells in the bone marrow in vivo.

Original languageEnglish (US)
Pages (from-to)2510-2513
Number of pages4
JournalCancer Research
Issue number9
StatePublished - May 1 1989
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Immunofluorescent Monoclonal Antibody Detection of Breast Cancer in Bone Marrow: Sensitivity in a Model System'. Together they form a unique fingerprint.

Cite this